SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-009859
Filing Date
2024-04-02
Accepted
2024-04-02 18:32:01
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04022024_100453.html 4  
1 form4-04022024_100453.xml 4 7476
  Complete submission text file 0001415889-24-009859.txt   9126
Mailing Address C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 94538
Business Address
Riley Antony A (Reporting) CIK: 0001339375 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 24816196

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)